In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


This content is currently on FREE ACCESS, enjoy another 54 days of free consultation

In these unprecedented times, the ESC is doing everything it can to support its community: FREE access to all ESC 365 content until 31 July: explore more than 125,000 educational resources.

From 1 August onwards, support our mission by becoming a member.

Blood pressure control in a registry of clinical practice, PINNACLE-BRAZIL REGISTRY

Session Poster Session 7

Speaker Alvaro Avezum

Event : ESC Congress 2019

  • Topic : hypertension
  • Sub-topic : Hypertension - Treatment
  • Session type : Poster Session

Authors : A Avezum (Sao Paulo,BR), A Cordeiro Mattos (Sao Paulo,BR), GBF Oliveira (Sao Paulo,BR), IM Pinto (Sao Paulo,BR), AR Rombaldi (Sao Paulo,BR), HAR Fonseca (Sao Paulo,BR), JI Bocchese (Sao Paulo,BR), G Saback (Sao Paulo,BR), PRC Taborga (Sao PAulo,BR), TO Silva (Sao Paulo,BR), RN Campoa (Sao Paulo,BR), MHB Ferreira (Sao Paulo,BR), F Savioli Neto (Sao Paulo,BR), CC Magalhaes (Sao Paulo,BR), JFK Saraiva (Sao Paulo,BR)

Authors:
A Avezum1 , A Cordeiro Mattos1 , GBF Oliveira2 , IM Pinto2 , AR Rombaldi1 , HAR Fonseca1 , JI Bocchese1 , G Saback1 , PRC Taborga3 , TO Silva1 , RN Campoa1 , MHB Ferreira1 , F Savioli Neto2 , CC Magalhaes1 , JFK Saraiva1 , 1Cardiology Society of Sao Paulo (SOCESP) - Sao Paulo - Brazil , 2Institute Dante Pazzanese of Cardiology - Sao Paulo - Brazil , 3Clinica de Especialidades GLOBALMED - Sao PAulo - Brazil ,

On behalf: PINNACLE Brazil Registry

Citation:

Introduction: The prevalence of hypertension is estimated to be nearly 50% among Brazilian adults. Achieving an adequate control of this CVD risk factor is challenging but truly relevant on a public health perspective, as this is the top-ranking cause of all deaths globally.
Purpose: We aimed to describe crude and simple metrics of blood pressure management (including its control), as based on current guideline-derived recommendations, after one year of the clinical practice registry
Methods: Patients with documented Hypertension were included by using electronic case report form based on the ACC PINNACLE Registry. The registry has been enrolling patients from general practitioners and specialists. The main goal of the PINNACLE program is to improve the quality of care in "real world" clinical practice. Patients data were evaluated after 01 year of follow-up on regular clinical appointments and the differences on clinical practice were evaluated
Results: Currently, PINNACLE-Brazil has enrolled 7598 patients, with 87% of diagnosed hypertension. Percentage of patients with a diagnosis of hypertension who had a blood pressure measurement <140/90 mmHg was 47.9%(baseline) and 57.3% (follow-up). Percentage of patients who had a blood pressure < 140/90 mm Hg, or who had a blood pressure >= 140/90 mm Hg and were prescribed >= 2 antihypertensive medications were 67.1% on baseline  and 71.2% after 1 year.
Conclusion: The preliminary data of PINNACLE Registry in Brazil shows that a significant proportion of hypertensive patients (nearly half) have not presented with adequate control of blood pressure levels and, moreover, a large proportion have not been treated with recommended combination of 02 or more antihypertensive medications to reach targeted BP levels the quality of care was improving after 01 year of registry.

This content is currently on FREE ACCESS, enjoy another 54 days of free consultation

In these unprecedented times, the ESC is doing everything it can to support its community: FREE access to all ESC 365 content until 31 July: explore more than 125,000 educational resources.

From 1 August onwards, support our mission by becoming a member.



Based on your interests

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are